Study shows Advair performs better than Singulair for asthma & allergic rhinitis
The results of a 660 subject study presented at the International Conference of the American Thoracic Society meeting in Toronto showed that asthma and allergic rhinitis patients responded better to Advair than Singulair.
The study included people aged 15 and over who suffered from both persistent asthma and seasonal allergies. Patients were given one of four different treatments: Singulair 10 mg once daily, Advair Diskus 100/50 twice daily, Advair 100/50 twice daily with Singulair 10 mg once daily or Advair 100/50 twice daily with fluticasone propionate nasal spray 200 mcg once daily.
The results of the study showed that patients who received only Advair experienced significant improvements in their morning peak expiratory flow which is a measure of asthma control, compared with Singulair alone (p<0.001).
Symptom free days and rescue treatment free days were also significantly increased in the Advair group compared with the Singulair group. However, the incidence of adverse events was similar among all groups.
The study was said to provide ”a greater understanding of how to treat patients with asthma and seasonal allergies, two diseases that often are seen in tandem,” according to Rohit Katial, MD, National Jewish Medical Research Center.
Leave a Reply
You must be logged in to post a comment.
